These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 13865768)

  • 1. Antibody response and survival following booster injections of poliomyelitis (killed-virus) vaccine.
    BATSON R; CHRISTIE A; CHEATHAM WJ; MICHAL ML; SLEIGHT GW
    Pediatrics; 1962 Jan; 29():116-20. PubMed ID: 13865768
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibody response of infants to a "booster" dose of the Salk type of poliomyelitis vaccine given from 5 to 6 months after early primary immunization].
    MORRONE G; NUNZIATA B
    Pediatria (Napoli); 1961; 69():851-6. PubMed ID: 14476315
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistence of antibody following booster dose of poliomyelitis vaccine.
    WILSON RJ; MOSS GW; JACOBS JP; MACLEOD DR
    Can J Public Health; 1962 Jan; 53():17-21. PubMed ID: 14007415
    [No Abstract]   [Full Text] [Related]  

  • 4. Further observations on the persistence of antibody in adolescents after a third dose of killed poliomyelitis vaccine.
    KENDALL EJ; MILLER A; TOBIN JO
    Br Med J; 1961 Jan; 1(5220):176-7. PubMed ID: 13752460
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody response and survival after booster injections of poliomyelitis vaccine.
    BATSON R; CHRISTIE A; CHEATHAM WJ; MICHAL ML; SLEIGHT GW
    Clin Med (Northfield); 1962 Nov; 69():2495-7. PubMed ID: 15445940
    [No Abstract]   [Full Text] [Related]  

  • 6. [2 1/2 Years of antipoliomyelitis vaccination (Lepine vaccine) at the Institut Pasteur hospital. Immunological results. Significance of the booster injection].
    MARTIN R; ROGER F; DAMAS JP; ROGER A
    Ann Inst Pasteur (Paris); 1959 Dec; 97():757-79. PubMed ID: 14421731
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-poliomyelitis vaccination with inactivated virus (Lepine vaccine). Effect of the booster injection on immunization].
    MARTIN R; ROGER F; DAMAS JP; ROGER A; JUILLARD P
    Bull Acad Natl Med; 1961 Nov 21-28; 145():664-73. PubMed ID: 14470436
    [No Abstract]   [Full Text] [Related]  

  • 8. Present situation with formalin-killed poliomyelitis vaccine.
    KNOWELDEN J
    Br Med J; 1959 Mar; 1(5122):620-1. PubMed ID: 13629068
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the antibody response to basic immunizing treatment carried out with 2 or 3 injections of antipoliomyelitic vaccine (Salk type)].
    SANTOPADRE G; CASAROSA S; RUSCHI A; ZERBONI R
    Riv Ital Ig; 1961; 21():192-204. PubMed ID: 14497064
    [No Abstract]   [Full Text] [Related]  

  • 10. Duration of seroimmunity after injection with ultraviolet-irradiated poliomyelitis vaccine; role of booster inoculations.
    WOLF AM; SHAUGHNESSY HJ; JANOTA M; CHAPMAN JW; CHURCH RE; MOORE M
    J Am Med Assoc; 1959 Jun; 170(6):650-2. PubMed ID: 13654006
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody response to poliomyelitis vaccine administered by jet injection.
    LIPSON MJ; CARVER DH; ELEFF MG; HINGSON RA; ROBBINS FC
    Am J Public Health Nations Health; 1958 May; 48(5):599-603. PubMed ID: 13521099
    [No Abstract]   [Full Text] [Related]  

  • 12. Human and animal antibody responses to commercial poliomyelitis vaccine.
    KOKKO UP; MURRAY R
    Bull World Health Organ; 1960; 22(3-4):263-72. PubMed ID: 14410625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killed-virus vs. live-virus vaccines against polio.
    RIVERS TM
    J Med Assoc State Ala; 1960 Oct; 30():237-40. PubMed ID: 13741947
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistence of antibody in adolescents and adults after a third, booster, dose of poliomyelities vaccine.
    KENDALL EJ; BESWICK TS; MILLER A; TOBIN JO
    Br Med J; 1960 Jun; 1(5187):1689-91. PubMed ID: 14408469
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunologic response to a booster injection following an early vaccination against poliomyelitis].
    BUTLER N
    Rev Immunol Ther Antimicrob; 1960; 24():249-50. PubMed ID: 13806504
    [No Abstract]   [Full Text] [Related]  

  • 16. [Virus excretion and antibody formation after double oral poliomyelitis vaccination (Cox triple vaccine and Sabin vaccine)].
    JUST M; BUERGIN-WOLFF A
    Ann Paediatr; 1962; 199():245-9. PubMed ID: 14452877
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody response in infants to the poliomyelitis component of a quadruple vaccine.
    HILLARY IB; MEENAN PN; GOFFE AP; KNIGHT GJ; KANAREK AD; POLLOCK TM
    Br Med J; 1962 Apr; 1(5285):1098-102. PubMed ID: 13907392
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody response to two different live poliomyelitis virus vaccines.
    HOTCHIN J; PLAGER H; DECHER W; JACOBS J
    N Y State J Med; 1962 Jun; 62():1776-83. PubMed ID: 14449209
    [No Abstract]   [Full Text] [Related]  

  • 19. The relationship between specific skin reaction and neutralizing antibody titers in the young infant following immunization with poliomyelitis (Salk-type) vaccine.
    MORRONE G; NUNZIATA B
    Ann Paediatr; 1961; 196():389-98. PubMed ID: 13772899
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies in human subjects on active immunization against poliomyelitis. II. A practical means for inducing and maintaining antibody formation.
    SALK JE; BAZELEY PL; BENNETT BL; KRECH U; LEWIS LJ; WARD EN; YOUNGNER JS
    Am J Public Health Nations Health; 1954 Aug; 44(8):994-1009. PubMed ID: 13180761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.